Change text size  A -  A +   Text Only Site

Call our support line on 1800 111 709



Is anything more precious than our sight?

Macular Degeneration (MD) is the leading cause of blindness in Australia, affecting central vision. MD is primarily age related and most frequently affects people over the age of 50. One in seven people over the age of 50 are affected by the disease and the incidence increases with age. It is sometimes referred to as Age Related Macular Degeneration or 'AMD'.

Coinciding with the Foundation’s research announcement is the launch of a Deloitte Access Economics Report commissioned by the Macular Degeneration Foundation. This report provides the most current, comprehensive compilation of Macular Degeneration statistics and latest research ever undertaken in Australia.

Click here for more information


Media Release
2012 Federal Budget reassuring for Macular Degeneration patients

The Macular Degeneration Foundation (MDF) is relieved that the Federal Government's budget announcement to introduce a cap on the Medicare item number for the treatment of wet Age-related Macular Degeneration (AMD), the leading cause of blindness in Australia should have minimal impact on patients, said MDF CEO, Julie Heraghty.

To download the media release click here.

For more information click here.

The Blackmores Dr Paul Beaumont Fellowship for 2013 is now open!

Blackmores and the MD Foundation are joining forces to offer the Blackmores Dr Paul Beaumont Research Fellowship for research into nutritional or lifestyle aspects of Macular Degeneration. The Fellowship will support an Australian-based researcher in conducting vital research to reduce the incidence and/or impact of MD.
The two-year Fellowship will provide the recipient with AU$50,000 per annum in 2013-14. Applications close on 22 June 2012.

Further information and application documents are available here.

A low glycemic index diet helps reduce risk of MD

There is now good evidence that people who eat a higher proportion of carbohydrates with a low glycemic index (GI) compared to high GI, have a lower risk of developing Macular Degeneration (MD).

For more information click here.

Macular Degeneration Foundation Autumn 2012 Newsletter

The Foundation's Autumn newsletter is now available. This newsletter updates you on the Federal Government funding renewal process, provides information on Macular Degeneration Awareness Week 2012, details about Telstra's low vision services, the latest in our Low Vision Aids and Technology Campaign and Private Health Fund Rebates.

To download your pdf copy click here.

TGA approves Eylea® (aflibercept, VEGF Trap-Eye) in Australia

The Macular Degeneration Foundation welcomes the Australian approval of Eylea® (aflibercept, VEGF Trap-Eye) by the TGA (Therapeutic Goods Administration) for the treatment of wet Age-related Macular Degeneration (AMD).

To read more click here.

Hyperbaric Oxygen Treatment – The Foundation’s Position

A number of Australia’s peak medical and patient advocacy groups are advising patients to be careful of alternate treatments that are advertised in newspapers or on the internet claiming dramatic success in the treatment of MD.

For more information click here


Macular Degeneration One Decade Gala Fundraising Dinner 2011

At the launch of Macular Degeneration Awareness Week 2011, the Foundation celebrated one decade of service to the Macular Degeneration community with a gala fundraising dinner at the Sydney Hilton Hotel on Friday 20 May. It was a wonderful evening acknowledging so many supporters and expressing our heartfelt thanks for the enormous contribution of Dr Paul Beaumont, our founding director

For more information click here


Winter Newsletter Now Available!

View our special One Decade edition which highlights the launch of MD Awareness Week 2011, the launch of the Macular Degeneration Foundation Research Grants Program, our One Decade Gala Fundraising Dinner, the mEYE World Photographic Competition Winners and our new publication Low Vision Aids & Technology – A Guide.

To find out more click here


Now Available, Low Vision Aids and Technology – A Guide

Low Vision Aids and Technology – A Guide, the fourth in a series on guides produced by the Foundation, provides information on the different types of aids and technology available to assist those living with low vision.

To find out more click here



Eye Health Checklist

To find out more about how to reduce your risk
Click here
It is vital to have your eyes checked regularly, including your macula.
To test yourself using an Amsler Grid
Click here


Facts & Figures

Statistical information on prevalence, risk factors and the cost of MD in Australia.
Click here

 















New !
Low Vision Aids &
Technology - A Guide

Answers key questions
and gives examples
of low vision aids
and technology.

Low Vision -A Guide
Coping strategies, low
vision tips for the
recently diagnosed
and a detailed service
directory of low vision
organisations

Family, Friend &
Carer - A Guide

provides information
for carers who
support people who
are blind or have low
vision

Slips, Trips & Falls -
A Guide

Practical advice to
avoid slips, trips and
falls





Top